Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Jeffrey D Marrazzo. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Jeffrey D Marrazzo har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:ONCE / Spark Therapeutics, Inc. CHIEF EXECUTIVE OFFICER, Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Jeffrey D Marrazzo. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Jeffrey D Marrazzo som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
D - Sale to Issuer -49.250 0 -100,00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -126.131 0 -100,00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -125.000 0 -100,00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -135.000 0 -100,00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -70.000 0 -100,00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -52.500 0 -100,00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -98.000 0 -100,00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Common Stock
U - Other -355.215 0 -100,00 114,50 -40.672.118
2019-03-19 2019-03-15 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -49.940 126.131 -28,36
2019-03-19 2019-03-15 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 49.940 355.215 16,36 3,45 172.293 1.225.492
2019-01-23 2019-01-18 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.750 11.250 -25,00
2019-01-23 2019-01-18 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
M - Exercise -5.000 10.000 -33,33
2019-01-23 2019-01-18 4 ONCE Spark Therapeutics, Inc.
Common Stock
F - Taxes -1.174 305.275 -0,38 45,08 -52.924 13.761.797
2019-01-23 2019-01-18 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 3.750 306.449 1,24
2019-01-23 2019-01-18 4 ONCE Spark Therapeutics, Inc.
Common Stock
F - Taxes -1.655 302.699 -0,54 45,08 -74.607 13.645.671
2019-01-23 2019-01-18 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 5.000 304.354 1,67
2019-01-17 2019-01-15 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
A - Award 28.000 28.000
2019-01-17 2019-01-15 4 ONCE Spark Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 98.000 98.000
2019-01-02 2018-12-28 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -6.000 176.071 -3,30
2019-01-02 2018-12-28 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 6.000 299.354 2,05 3,45 20.700 1.032.771
2018-01-22 2018-01-18 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
M - Exercise -5.000 15.000 -25,00
2018-01-22 2018-01-18 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
A - Award 15.000 15.000
2018-01-22 2018-01-18 4 ONCE Spark Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 52.500 52.500
2018-01-22 2018-01-18 4 ONCE Spark Therapeutics, Inc.
Common Stock
F - Taxes -1.646 293.354 -0,56 50,55 -83.205 14.829.045
2018-01-22 2018-01-18 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 5.000 295.000 1,72
2017-12-20 2017-12-19 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -60.000 182.071 -24,79
2017-12-20 2017-12-19 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 60.000 290.000 26,09 3,45 207.000 1.000.500
2017-11-13 2017-11-13 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -20.000 242.071 -7,63
2017-11-13 2017-11-13 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -20.000 230.000 -8,00 71,54 -1.430.800 16.454.200
2017-11-13 2017-11-13 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 20.000 250.000 8,70 3,45 69.000 862.500
2017-08-24 2017-08-23 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -21.350 262.071 -7,53
2017-08-24 2017-08-23 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -21.350 230.000 -8,49 80,01 -1.708.214 18.402.300
2017-08-24 2017-08-23 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 21.350 251.350 9,28 3,45 73.658 867.158
2017-08-15 2017-08-11 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -15.000 283.421 -5,03
2017-08-15 2017-08-11 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -15.000 230.000 -6,12 75,10 -1.126.500 17.273.000
2017-08-15 2017-08-11 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 15.000 245.000 6,52 3,45 51.750 845.250
2017-08-04 2017-08-02 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -28.650 298.421 -8,76
2017-08-04 2017-08-02 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -28.650 230.000 -11,08 80,01 -2.292.286 18.402.300
2017-08-04 2017-08-02 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 28.650 258.650 12,46 3,45 98.842 892.342
2017-07-07 2017-07-05 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -5.669 327.071 -1,70
2017-07-07 2017-07-05 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -5.669 230.000 -2,41 65,00 -368.485 14.950.000
2017-07-07 2017-07-05 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 5.669 235.669 2,46 3,45 19.558 813.058
2017-06-22 2017-06-21 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -8.797 332.740 -2,58
2017-06-22 2017-06-21 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -8.797 230.000 -3,68 65,00 -571.805 14.950.000
2017-06-22 2017-06-21 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 8.797 238.797 3,82 3,45 30.350 823.850
2017-06-22 2017-06-20 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -534 341.537 -0,16
2017-06-22 2017-06-20 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -534 230.000 -0,23 65,00 -34.710 14.950.000
2017-06-22 2017-06-20 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 534 230.534 0,23 3,45 1.842 795.342
2017-01-20 2017-01-18 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
A - Award 20.000 40.000 100,00
2017-01-20 2017-01-18 4 ONCE Spark Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 70.000 70.000
2016-10-19 2016-10-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -5.000 342.071 -1,44
2016-10-19 2016-10-17 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -300 230.000 -0,13 55,71 -16.713 12.813.300
2016-10-19 2016-10-17 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -2.300 230.300 -0,99 55,11 -126.753 12.691.833
2016-10-19 2016-10-17 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -2.400 232.600 -1,02 54,10 -129.840 12.583.660
2016-10-19 2016-10-17 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 5.000 235.000 2,17 3,45 17.250 810.750
2016-09-19 2016-09-16 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -10.000 347.071 -2,80
2016-09-19 2016-09-16 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -3.810 230.000 -1,63 63,54 -242.087 14.614.200
2016-09-19 2016-09-16 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -3.369 233.810 -1,42 62,53 -210.664 14.620.139
2016-09-19 2016-09-16 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -2.821 237.179 -1,18 61,71 -174.084 14.636.316
2016-09-19 2016-09-16 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 10.000 240.000 4,35 3,45 34.500 828.000
2016-08-17 2016-08-15 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -10.000 357.071 -2,72
2016-08-17 2016-08-15 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -100 230.000 -0,04 64,64 -6.464 14.867.200
2016-08-17 2016-08-15 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -3.400 230.100 -1,46 63,96 -217.464 14.717.196
2016-08-17 2016-08-15 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -1.500 233.500 -0,64 62,84 -94.260 14.673.140
2016-08-17 2016-08-15 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -5.000 235.000 -2,08 61,84 -309.200 14.532.400
2016-08-17 2016-08-15 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 10.000 240.000 4,35 3,45 34.500 828.000
2016-08-12 2016-08-11 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -9.999 367.071 -2,65
2016-08-12 2016-08-11 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -9.999 230.000 -4,17 60,06 -600.540 13.813.800
2016-08-12 2016-08-11 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 9.999 239.999 4,35 3,45 34.497 827.997
2016-08-12 2016-08-10 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -6.971 377.070 -1,82
2016-08-12 2016-08-10 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -6.971 230.000 -2,94 60,02 -418.399 13.804.600
2016-08-12 2016-08-10 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 6.971 236.971 3,03 3,45 24.050 817.550
2016-08-08 2016-08-08 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -800 384.041 -0,21
2016-08-08 2016-08-08 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -800 230.000 -0,35 60,27 -48.216 13.862.100
2016-08-08 2016-08-08 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 800 230.800 0,35 3,45 2.760 796.260
2016-08-08 2016-08-04 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -100 384.841 -0,03
2016-08-08 2016-08-04 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -100 230.000 -0,04 60,00 -6.000 13.800.000
2016-08-08 2016-08-04 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 100 230.100 0,04 3,45 345 793.845
2016-08-03 2016-08-03 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4.182 384.941 -1,07
2016-08-03 2016-08-03 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -4.182 230.000 -1,79 60,00 -250.920 13.800.000
2016-08-03 2016-08-03 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 4.182 234.182 1,82 3,45 14.428 807.928
2016-08-03 2016-08-01 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -12.348 389.123 -3,08
2016-08-03 2016-08-01 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -12.348 230.000 -5,10 60,03 -741.250 13.806.900
2016-08-03 2016-08-01 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 12.348 242.348 5,37 3,45 42.601 836.101
2016-07-19 2016-07-18 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -5.000 401.471 -1,23
2016-07-19 2016-07-18 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -5.000 230.000 -2,13 52,53 -262.650 12.081.900
2016-07-19 2016-07-18 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 5.000 235.000 2,17 3,45 17.250 810.750
2016-06-16 2016-06-15 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -5.000 406.471 -1,22
2016-06-16 2016-06-15 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -300 230.000 -0,13 49,04 -14.712 11.279.200
2016-06-16 2016-06-15 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -900 230.300 -0,39 47,75 -42.975 10.996.825
2016-06-16 2016-06-15 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -1.300 231.200 -0,56 46,53 -60.489 10.757.736
2016-06-16 2016-06-15 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -2.500 232.500 -1,06 45,71 -114.275 10.627.575
2016-06-16 2016-06-15 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 5.000 235.000 2,17 3,45 17.250 810.750
2016-06-02 2016-05-31 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -600 411.471 -0,15
2016-06-02 2016-05-31 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -600 230.000 -0,26 60,00 -36.000 13.800.000
2016-06-02 2016-05-31 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 600 230.600 0,26 3,45 2.070 795.570
2016-05-23 2016-05-19 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -25.000 412.071 -5,72
2016-05-23 2016-05-19 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -4.658 230.000 -1,99 47,14 -219.578 10.842.200
2016-05-23 2016-05-19 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -6.038 234.658 -2,51 46,49 -280.707 10.909.250
2016-05-23 2016-05-19 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale X -14.304 240.696 -5,61 45,44 -649.974 10.937.226
2016-05-23 2016-05-19 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 25.000 255.000 10,87 3,45 86.250 879.750
2016-01-07 2016-01-05 4 ONCE Spark Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 135.000 135.000
2015-10-14 2015-10-12 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale -21.735 230.000 -8,63 50,08 -1.088.489 11.518.400
2015-10-14 2015-10-12 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale -2.500 251.735 -0,98 51,00 -127.500 12.838.485
2015-10-14 2015-10-12 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale -10.765 254.235 -4,06 48,11 -517.904 12.231.246
2015-10-14 2015-10-12 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale -40.000 265.000 -13,11 47,30 -1.892.000 12.534.500
2015-10-09 2015-10-09 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale -20.000 305.000 -6,15 48,17 -963.400 14.691.850
2015-10-09 2015-10-09 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale -4.983 325.000 -1,51 47,48 -236.593 15.431.000
2015-10-09 2015-10-07 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale -25.000 329.983 -7,04 47,02 -1.175.500 15.515.801
2015-10-09 2015-10-07 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale -24.117 354.983 -6,36 48,33 -1.165.575 17.156.328
2015-10-09 2015-10-07 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale -900 379.100 -0,24 50,40 -45.360 19.106.640
2015-03-18 2015-03-16 4 ONCE Spark Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 125.000 125.000
2015-01-29 3 ONCE Spark Therapeutics, Inc.
Common Stock
760.000
2015-01-29 3 ONCE Spark Therapeutics, Inc.
Common Stock
760.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)